After being vaccinated with AstraZeneca’s covida-19 vaccine, the French Medicines Agency found three new cases of thrombosis in the “atypical” site.
According to ASNM News Agency, these cases of blood clots related to the vaccine were reported during the week from March 19 to 25.
Since the start of the vaccination campaign, there have been 12 cases in France, 4 of which were fatal.
In the reported cases, thrombosis mainly occurred within nine days after vaccination.
Most of the affected are women. In 9 cases, the vaccinators were younger than 55 years old, and 3 cases were older.
After a short break during the vaccination period in mid-March, most French health authorities have advised people over 55 to receive the AstraZeneca vaccine.
As of March 25, France has injected 1.9 million doses of AstraZeneca vaccine.
In Germany, the federal and state health ministers decided on Tuesday that the vaccine should generally be given to people over 60 years old, unless young people take the risk after consulting a doctor, or they should do it themselves.
Since the beginning of this week, 31 suspected cases of cerebral vein thrombosis after AstraZeneca vaccination have been reported.
By Friday, more than 9 million people had received at least one and two doses of the vaccine. This accounts for approximately 13.6% of the total population.
French President Emmanuel Macron recently announced that starting in mid-April, anyone over the age of 60 can be vaccinated with covid-19.
Starting in mid-May, people over the age of 50 began to pay attention.
By the end of summer, all people over the age of 18 who wish to be vaccinated should be vaccinated.